Human–computer interaction

Insights on the Linear Vibration Motor Global Market to 2027 - Featuring Nidec, AAC Technologies and Samsung Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, September 6, 2021

The global linear vibration motor market was valued at USD 1,397.8 Million in 2020 and is projected to reach USD 2,498.0 Million by the year 2027.

Key Points: 
  • The global linear vibration motor market was valued at USD 1,397.8 Million in 2020 and is projected to reach USD 2,498.0 Million by the year 2027.
  • Linear vibration motors or linear resonant actuators are precision vibration motors that can produce an oscillating force across a single axis.
  • The increasing adoption of smartphones and high demand for game devices is expected to boost the market growth.
  • However, the low-cost alternative of eccentric rotating mass (ERM) vibration motor is anticipated to hinder the market growth.

Formation Secures First Gaming System Patent

Retrieved on: 
Wednesday, August 4, 2021

Formation , the pioneer in machine learning-powered offer optimization, today announced that it has been awarded a new patent covering its recently launched Dynamic Offer Optimization platform .

Key Points: 
  • Formation , the pioneer in machine learning-powered offer optimization, today announced that it has been awarded a new patent covering its recently launched Dynamic Offer Optimization platform .
  • The interactive gaming system patent , published by the U.S. Patent Office as U.S. Patent No.
  • Authors of the patent are Formation CEO Christian Selchau-Hansen, along with Stas Goldobin, Chris McKinlay and Greg Pfeil.
  • This new patent further extends the unique and proprietary personalization capabilities of the Formation platform for B2C marketers, observed Selchau-Hansen.

Reliefband® Expands Innovative Lineup of Nausea Prevention Products with General Availability of Reliefband® Sport

Retrieved on: 
Wednesday, August 4, 2021

HORSHAM, Pa., Aug. 4, 2021 /PRNewswire-PRWeb/ -- Reliefband , an innovator in wearable technology that prevents and treats nausea and vomiting symptoms, announced the availability of Reliefband Sport , a new IPX7-designated waterproof wearable therapeutic device.

Key Points: 
  • HORSHAM, Pa., Aug. 4, 2021 /PRNewswire-PRWeb/ -- Reliefband , an innovator in wearable technology that prevents and treats nausea and vomiting symptoms, announced the availability of Reliefband Sport , a new IPX7-designated waterproof wearable therapeutic device.
  • Reliefband Sport is a clinically proven wearable includes a built-in rechargeable battery that, when fully charged, will last 30 hours on the medium intensity level.
  • "With Reliefband Sport, we went even further by introducing an all-new waterproof model that provides 30 hours of use on a full charge.
  • The Reliefband Sport is priced at $229.99 and is available now direct from Reliefband.

Global Rain RFID Solutions Market (2021 to 2029) - Evolving RFID Trends and Rise in Discretionary Income is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 3, 2021

The global Rain RFID solutions market is projected to grow at a CAGR of 14 % during the forecast period of 2021 to 2029.

Key Points: 
  • The global Rain RFID solutions market is projected to grow at a CAGR of 14 % during the forecast period of 2021 to 2029.
  • Rain RFID tags are used majorly for sales, they are attached or embedded to stored items which send information.
  • What is the key impact of Covid-19 over market revenues and market determinants in the Rain RFID Solutions market?
  • Who are the key players in the Rain RFID Solutions market and what are their key product categories and strategies?

Earnix Enhances its Rating and Pricing Solutions to Maximize Transparency and Governance

Retrieved on: 
Tuesday, August 3, 2021

Today, Earnix , a leading provider of advanced rating, pricing and product personalization solutions for insurers and banks, announced robust enhancements to the rating and pricing system designed to increase transparency, assure compliance, and build consumer trust.

Key Points: 
  • Today, Earnix , a leading provider of advanced rating, pricing and product personalization solutions for insurers and banks, announced robust enhancements to the rating and pricing system designed to increase transparency, assure compliance, and build consumer trust.
  • At Earnix, we are focused on developing product enhancements that are responsive to the business objectives of insurers and banks and exceed consumer expectations.
  • Earnix continuously enhances its products to further empower insurers and banks to provide dynamic rating and pricing solutions that meet consumer needs in real time with highly personalized product offerings.
  • Earnix has been innovating for Insurers and Banks since 2001 with offices in the Americas, Europe, Asia Pacific, and Israel.

LumenVox Launches Next-Generation Automatic Speech Recognition Engine with Transcription

Retrieved on: 
Tuesday, August 3, 2021

LumenVox , a leading provider of speech and voice technology, today announced its next-generation Automatic Speech Recognition (ASR) engine with transcription.

Key Points: 
  • LumenVox , a leading provider of speech and voice technology, today announced its next-generation Automatic Speech Recognition (ASR) engine with transcription.
  • The new LumenVox ASR engine stands apart from the rest with its end-to-end Deep Neural Network (DNN) architecture and its state-of-the-art speech recognition processing capabilities.
  • New demands have redefined the very meaning of Automated Speech Recognition, said Dan Miller, lead analyst at Opus Research.
  • Migrate legacy speech applications: Through the LumenVox Speech Tuner, customers can migrate over 80% of their grammars and confidence values from legacy applications to the LumenVox ASR with relative ease.

Kestra Medical Technologies Receives FDA Premarket Approval for ASSURE Wearable Cardioverter Defibrillator (WCD)

Retrieved on: 
Tuesday, August 3, 2021

Kestra Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE Wearable Cardioverter Defibrillator (WCD) system.

Key Points: 
  • Kestra Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE Wearable Cardioverter Defibrillator (WCD) system.
  • The ASSURE WCD system represents the next generation of monitoring and therapy to protect patients at risk of Sudden Cardiac Death (SCD).
  • The system includes a modern, comfortable wearable device with integrated sensors, a cardiac rhythm monitor and miniaturized automated external defibrillator.
  • Kestra Medical Technologies, Inc. is a privately held wearable medical device and digital healthcare company that protects cardiac patients with diagnostic monitoring and therapeutic technologies that are intuitive, intelligent, and mobile.

Worldwide Rain RFID Solutions Industry to 2029 - Featuring NXP Semiconductors, Walki Group and SMARTRAC Among Others

Retrieved on: 
Tuesday, August 3, 2021

The global Rain RFID solutions market is projected to grow at a CAGR of 14 % during the forecast period of 2021 to 2029.

Key Points: 
  • The global Rain RFID solutions market is projected to grow at a CAGR of 14 % during the forecast period of 2021 to 2029.
  • Rain RFID tags are used majorly for sales, they are attached or embedded to stored items which send information.
  • The rain RFID technology is widely used for apparel tagging in the apparel industry across the globe.
  • Who are the key players in the Rain RFID Solutions market and what are their key product categories and strategies?

Avidity Science Expands Biomedical Research Solutions Through Acquisition of UMG, Inc.

Retrieved on: 
Tuesday, August 3, 2021

WATERFORD, Wis., Aug. 3, 2021 /PRNewswire/ --Today, Avidity Science announces another significant step in expanding its global leadership in biomedical research solutions via the acquisition of UMG, Inc.

Key Points: 
  • WATERFORD, Wis., Aug. 3, 2021 /PRNewswire/ --Today, Avidity Science announces another significant step in expanding its global leadership in biomedical research solutions via the acquisition of UMG, Inc.
  • This investment expands Avidity's Radio Frequency Identification (RFID) solutions, enhancing its support of the global biomedical research community.
  • "We are excited about this investment as it adds unique design, engineering and manufacturing capacity of RFID transponders and readers used in research model identification," said Doug Lohse, chief executive officer, Avidity Science.
  • Avidity Science is a worldwide leader in water purification and delivery, control and monitoring and service solutions for the life science and biomedical research communities.

Avidity Science Expands Biomedical Research Solutions Through Acquisition of UMG, Inc.

Retrieved on: 
Tuesday, August 3, 2021

WATERFORD, Wis., Aug. 3, 2021 /PRNewswire/ -- Today, Avidity Science announces another significant step in expanding its global leadership in biomedical research solutions via the acquisition of UMG, Inc.  This investment expands Avidity's Radio Frequency Identification (RFID) solutions, enhancing its support of the global biomedical research community.

Key Points: 
  • WATERFORD, Wis., Aug. 3, 2021 /PRNewswire/ --Today, Avidity Science announces another significant step in expanding its global leadership in biomedical research solutions via the acquisition of UMG, Inc.
  • This investment expands Avidity's Radio Frequency Identification (RFID) solutions, enhancing its support of the global biomedical research community.
  • "We are excited about this investment as it adds unique design, engineering and manufacturing capacity of RFID transponders and readers used in research model identification," said Doug Lohse, chief executive officer, Avidity Science.
  • Avidity Science is a worldwide leader in water purification and delivery, control and monitoring and service solutions for the life science and biomedical research communities.